The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
700 - Can we present two different brands, (which are two different therapeutic areas) in one APS (i.e. in a LB) as long as the indication and balancing info is presented for both brands?
-
The co-promotion of different products within a single APS is possible, even for different therapeutic areas. The key is that there is a clear separation of the content. For example, a two-sided card could promote drug A on the front, and drug B on the back. We can provide further direction on how to accomplish this during the review process.
